Evidence map›Paper›PMID 40851789›Full record

ArticleStatistics and computing2025

A Neural Network Integrated Accelerated Failure Time-Based Mixture Cure Model.

Wisdom Aselisewine, Suvra Pal

Abstract read
In one paragraph

Article in Statistics and computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Modeling Cure from Cancer Accounting for Inevitable Mortality.Journal of the Royal Statistical Society. Series C, Applied statistics · 2026
    Article
  3. A quantile cure model with partially functional covariate effects.Statistical methods in medical research · 2026
    Article
  4. Fitting high-dimensional mixture cure models using the hdcuremodelsR package.Computer methods and programs in biomedicine · 2026
    Article
  5. Article
  6. Machine Learning Approach for Analyzing Mixed Case Interval Censored Data with a Cured Subgroup.Advances in statistical analysis : AStA : a journal of the German Statistical Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wisdom AselisewineDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.
Suvra PalDepartment of Mathematics, University of Texas at Arlington, Arlington, TX 76019, United States.

Funding

Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional SettingsR35GM156859 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI SUVRA PAL · 2025 to 2026
$643k
Using Machine Learning to Improve the Predictive Accuracy of Disease CureR15GM150091 · NIGMS · UNIVERSITY OF TEXAS ARLINGTON · PI PAL, SUVRA · 2023 to 2023
$452k
NIGMS NIH HHS R15 GM150091NIGMS NIH HHS R35 GM156859
6 · The paper itself

Abstract

The mixture cure rate model (MCM) is commonly used for analyzing survival data with a cured subgroup. While the prevailing approach to modeling the probability of cure involves a generalized linear model using a known parametric link function, such as the logit link function, it has limitations in capturing the complex effects of covariates on cure probability. This paper introduces a novel MCM employing a neural network-based classifier for cure probability and an accelerated failure time structure for the survival distribution of uncured patients. An expectation maximization algorithm is developed for parameter estimation. Simulation results demonstrate the superior performance of the proposed model in capturing non-linear classification boundaries compared to logit-based and spline-based MCMs, as well as other machine learning algorithms. This enhances the accuracy and precision of cured probability estimates, improving predictive accuracy. The proposed model and estimation method are applied to survival data on leukemia cancer patients, showcasing their effectiveness.

Indexed as

Bone marrow transplantationEM algorithmLong-term survivorsMachine learningMultiple imputation

Identifiers

PMID40851789
PMCPMC12369597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.